Education
About Us
Working with TipRanks
Follow Us
Amphastar Pharmaceuticals (AMPH)
NASDAQ:AMPH
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 719.89M | $ 731.97M | $ 644.39M | $ 498.99M | $ 437.77M |
| Gross Profit | $ 356.06M | $ 373.86M | $ 351.12M | $ 248.86M | $ 199.74M |
| Operating Income | $ 140.40M | $ 205.42M | $ 196.99M | $ 107.50M | $ 69.89M |
| EBITDA | $ 149.10M | $ 277.31M | $ 240.29M | $ 146.16M | $ 111.56M |
| Net Income | $ 98.09M | $ 159.52M | $ 137.54M | $ 91.39M | $ 62.12M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 282.81M | $ 221.65M | $ 256.81M | $ 175.76M | $ 136.67M |
| Total Assets | $ 1.63B | $ 1.58B | $ 1.51B | $ 741.99M | $ 671.53M |
| Total Debt | $ 656.00M | $ 650.55M | $ 623.64M | $ 102.58M | $ 104.66M |
| Net Debt | $ 485.82M | $ 498.94M | $ 479.35M | $ -53.52M | $ -21.69M |
| Total Liabilities | $ 840.49M | $ 845.17M | $ 873.49M | $ 213.33M | $ 226.01M |
| Stockholders' Equity | $ 788.80M | $ 732.30M | $ 639.42M | $ 528.66M | $ 445.52M |
| Cash Flow | |||||
| Free Cash Flow | $ 121.23M | $ 172.34M | $ 145.34M | $ 65.15M | $ 70.54M |
| Operating Cash Flow | $ 156.12M | $ 213.39M | $ 183.50M | $ 89.18M | $ 97.99M |
| Investing Cash Flow | $ -70.33M | $ -124.93M | $ -649.12M | $ -32.78M | $ -28.67M |
| Financing Cash Flow | $ -67.42M | $ -80.95M | $ 454.09M | $ -26.44M | $ -37.02M |